-
Something wrong with this record ?
Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy
H. Schlögl, A. Villringer, K. Miehle, M. Fasshauer, M. Stumvoll, K. Mueller
Status not-indexed Language English Country United States
Document type Journal Article
NLK
Directory of Open Access Journals
from 2017
PubMed Central
from 2017
Europe PubMed Central
from 2017
ProQuest Central
from 2017-01-01
Open Access Digital Library
from 2017-01-01
Nursing & Allied Health Database (ProQuest)
from 2017-01-01
Health & Medicine (ProQuest)
from 2017-01-01
Oxford Journals Open Access Collection
from 2017-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2017
- Publication type
- Journal Article MeSH
CONTEXT: Research in lipodystrophy (LD) and its treatment with metreleptin has not only helped patients with LD but has opened new directions in investigating leptin's role in metabolism and the regulation of eating behavior. Previously, in a study with patients with LD undergoing metreleptin treatment using functional magnetic resonance imaging (MRI), we found significantly increased resting-state brain connectivity in 3 brain areas including the hypothalamus. OBJECTIVE: In this study, we aimed to reproduce our functional MRI findings in an independent sample and compare results to healthy participants. DESIGN: Measurements in 4 female patients with LD undergoing metreleptin treatment and 3 healthy untreated controls were performed at 4 different time points over 12 weeks. To identify treatment-related brain connectivity alterations, eigenvector centrality was computed from resting-state functional MRI data for each patient and each session. Thereafter, analysis aimed at detecting consistent brain connectivity changes over time across all patients. RESULTS: In parallel to metreleptin treatment of the patients with LD, we found a significant brain connectivity increase in the hypothalamus and bilaterally in posterior cingulate gyrus. Using a 3-factorial model, a significant interaction between group and time was found in the hypothalamus. CONCLUSIONS: Investigating brain connectivity alterations with metreleptin treatment using an independent sample of patients with LD, we have reproduced an increase of brain connectivity in hedonic and homeostatic central nervous networks observed previously with metreleptin treatment. These results are an important contribution to ascertain brain leptin action and help build a foundation for further research of central nervous effects of this important metabolic hormone.
Day Clinic of Cognitive Neurology University of Leipzig 04103 Leipzig Germany
Institute of Nutritional Sciences Justus Liebig University 35392 Giessen Germany
Max Planck Institute for Human Cognitive and Brain Sciences 04103 Leipzig Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23015795
- 003
- CZ-PrNML
- 005
- 20231020093643.0
- 007
- ta
- 008
- 231010s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1210/jendso/bvad072 $2 doi
- 035 __
- $a (PubMed)37404242
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Schlögl, Haiko $u Department of Endocrinology, Nephrology, Rheumatology, Division of Endocrinology, University Hospital Leipzig, 04103 Leipzig, Germany $u Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, 04103 Leipzig, Germany $1 https://orcid.org/0000000239675318
- 245 10
- $a Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy / $c H. Schlögl, A. Villringer, K. Miehle, M. Fasshauer, M. Stumvoll, K. Mueller
- 520 9_
- $a CONTEXT: Research in lipodystrophy (LD) and its treatment with metreleptin has not only helped patients with LD but has opened new directions in investigating leptin's role in metabolism and the regulation of eating behavior. Previously, in a study with patients with LD undergoing metreleptin treatment using functional magnetic resonance imaging (MRI), we found significantly increased resting-state brain connectivity in 3 brain areas including the hypothalamus. OBJECTIVE: In this study, we aimed to reproduce our functional MRI findings in an independent sample and compare results to healthy participants. DESIGN: Measurements in 4 female patients with LD undergoing metreleptin treatment and 3 healthy untreated controls were performed at 4 different time points over 12 weeks. To identify treatment-related brain connectivity alterations, eigenvector centrality was computed from resting-state functional MRI data for each patient and each session. Thereafter, analysis aimed at detecting consistent brain connectivity changes over time across all patients. RESULTS: In parallel to metreleptin treatment of the patients with LD, we found a significant brain connectivity increase in the hypothalamus and bilaterally in posterior cingulate gyrus. Using a 3-factorial model, a significant interaction between group and time was found in the hypothalamus. CONCLUSIONS: Investigating brain connectivity alterations with metreleptin treatment using an independent sample of patients with LD, we have reproduced an increase of brain connectivity in hedonic and homeostatic central nervous networks observed previously with metreleptin treatment. These results are an important contribution to ascertain brain leptin action and help build a foundation for further research of central nervous effects of this important metabolic hormone.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Villringer, Arno $u Max-Planck-Institute for Human Cognitive and Brain Sciences, 04103 Leipzig, Germany $u Day Clinic of Cognitive Neurology, University of Leipzig, 04103 Leipzig, Germany $1 https://orcid.org/0000000326042404
- 700 1_
- $a Miehle, Konstanze $u Department of Endocrinology, Nephrology, Rheumatology, Division of Endocrinology, University Hospital Leipzig, 04103 Leipzig, Germany
- 700 1_
- $a Fasshauer, Mathias $u Institute of Nutritional Sciences, Justus-Liebig-University, 35392 Giessen, Germany
- 700 1_
- $a Stumvoll, Michael $u Department of Endocrinology, Nephrology, Rheumatology, Division of Endocrinology, University Hospital Leipzig, 04103 Leipzig, Germany $u Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, 04103 Leipzig, Germany $1 https://orcid.org/0000000162258240
- 700 1_
- $a Mueller, Karsten $u Max-Planck-Institute for Human Cognitive and Brain Sciences, 04103 Leipzig, Germany $u Department of Neurology, Charles University, First Faculty of Medicine and General University Hospital, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000196130552
- 773 0_
- $w MED00209724 $t Journal of the Endocrine Society $x 2472-1972 $g Roč. 7, č. 8 (2023), s. bvad072
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37404242 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231010 $b ABA008
- 991 __
- $a 20231020093637 $b ABA008
- 999 __
- $a ok $b bmc $g 1997269 $s 1202157
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 7 $c 8 $d bvad072 $e 20230606 $i 2472-1972 $m Journal of the Endocrine Society $n J Endocr Soc $x MED00209724
- LZP __
- $a Pubmed-20231010